| CAS ID: | 76-25-5 |
| Molecular Formula: | C24H31FO6 |
| Molecular Weight: | 434.5 g/mol |
| Monoisotopic Mass: | 434.2105 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | ZILRETTA | Tri-nasal | TRIAMCINOLONE ACETONIDE IN ABSORBASE | TRIACET | ADCORTYL | TRIATEX | KENACORT | GPPE EAR OINT | Vetalog | TRIESENCE | TRI-ADCORTYL | NASACORT ALLERGY 24 HOUR | NASACORT | KENALOG-40 | KENALOG IN ORABASE | GPPE EAR DPS CAP | ARISTOGEL | ARISTOCORT A | TRIDERM | SILDERM | REMOTIC | NYSTADERMAL | KENALOG-H | TRIAMCINOLONE ACETONIDE | PEVARYL T.C. | ORALONE | Kenacourt | KENALOG-10 | KENALOG | AZMACORT | AUDICORT | TRIVARIS | REMIDERM | NASACORT HFA | FLUTEX | TRYMEX | TRIACORT | Oracort | NASACORT AQ | AUREOCORT | ARISTOCORT | ALLERNAZE | ADCORTYL IN ORABASE |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C24H31FO6/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,25)17(28)11-22(16,4)24(19,31-20)18(29)12-26/h7-9,15-17,19,26,28H,5-6,10-12H2,1-4H3/t15-,16-,17-,19+,21-,22-,23-,24+/m0/s1 | See All |
| InChI Key: | YNDXUCZADRHECN-JNQJZLCISA-N | |
| Smiles: | CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT01978301 | Disease | Fibrosis |
| Phase | Phase 1 | Status | Terminated |
| First Received | November 7, 2013 | Last Verified | May 15, 2017 |
| Sponsor | GlaxoSmithKline | ||
Trial Record 2
| ClinicalTrial ID | NCT02962518 | Disease | Keloid |
| Phase | Not Applicable | Status | Completed |
| First Received | November 11, 2016 | Last Verified | November 11, 2016 |
| Sponsor | University of Ulm | ||
Trial Record 3
| ClinicalTrial ID | NCT01720056 | Disease | Keloid |
| Phase | Phase 4 | Status | Terminated |
| First Received | November 1, 2012 | Last Verified | June 10, 2015 |
| Sponsor | The University of Western Australia | ||
| PubChem: | 6436 |
| ChEMBL: | CHEMBL1504 |